‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Keeping Current CME
Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?
30
00:00:00
/ 00:55:18
30